These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28455742)

  • 1. Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell Death.
    Ueki S; Ohta N; Takeda M; Konno Y; Hirokawa M
    Curr Allergy Asthma Rep; 2017 May; 17(5):33. PubMed ID: 28455742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophil extracellular trap cell death-derived DNA traps: Their presence in secretions and functional attributes.
    Ueki S; Konno Y; Takeda M; Moritoki Y; Hirokawa M; Matsuwaki Y; Honda K; Ohta N; Yamamoto S; Takagi Y; Wada A; Weller PF
    J Allergy Clin Immunol; 2016 Jan; 137(1):258-267. PubMed ID: 26070883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil ETosis and DNA Traps: a New Look at Eosinophilic Inflammation.
    Ueki S; Tokunaga T; Fujieda S; Honda K; Hirokawa M; Spencer LA; Weller PF
    Curr Allergy Asthma Rep; 2016 Jul; 16(8):54. PubMed ID: 27393701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ETosis-derived DNA trap production in middle ear effusion is a common feature of eosinophilic otitis media.
    Ohta N; Ueki S; Konno Y; Hirokawa M; Kubota T; Tomioka-Matsutani S; Suzuki T; Ishida Y; Kawano T; Miyasaka T; Takahashi T; Suzuki T; Ohno I; Kakehata S; Fujieda S
    Allergol Int; 2018 Jul; 67(3):414-416. PubMed ID: 29242145
    [No Abstract]   [Full Text] [Related]  

  • 5. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
    Uchimizu H; Matsuwaki Y; Kato M; Otori N; Kojima H
    Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y; Kakizaki K; Katano H; Saigusa H; Kanegasaki S
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Insights into Eosinophilic Otitis Media.
    Kanazawa H; Yoshida N; Iino Y
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allergic Bronchopulmonary Aspergillosis-A Luminal Hypereosinophilic Disease With Extracellular Trap Cell Death.
    Ueki S; Hebisawa A; Kitani M; Asano K; Neves JS
    Front Immunol; 2018; 9():2346. PubMed ID: 30364279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo ETosis of Human Eosinophils: The Ultrastructural Signature Captured by TEM in Eosinophilic Diseases.
    Neves VH; Palazzi C; Bonjour K; Ueki S; Weller PF; Melo RCN
    Front Immunol; 2022; 13():938691. PubMed ID: 35874692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Quantification of Extracellular Trap Cell Death-Derived Products as Diagnostic Biomarkers for Otitis Media With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Eosinophilic Otitis Media.
    Morita S; Nakamaru Y; Fukuda A; Fujiwara K; Suzuki M; Hoshino K; Honma A; Homma A
    Otol Neurotol; 2022 Mar; 43(3):e337-e343. PubMed ID: 34802016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y; Takahashi E; Ida S; Kikuchi S
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eosinophilic otitis media and eosinophilic chronic -hinosinusitis].
    Matsubara A; Takahata J; Kudo N; Noro M; Miura T
    Nihon Rinsho; 2016 Oct; 74(10):1717-1720. PubMed ID: 30551286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Charcot-Leyden Crystals in Eosinophilic Inflammation: Active Cytolysis Leads to Crystal Formation.
    Ueki S; Miyabe Y; Yamamoto Y; Fukuchi M; Hirokawa M; Spencer LA; Weller PF
    Curr Allergy Asthma Rep; 2019 Jun; 19(8):35. PubMed ID: 31203469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eosinophilic otitis media and comorbid asthma.
    Seo Y; Nonaka M; Pawankar R
    Curr Opin Allergy Clin Immunol; 2020 Feb; 20(1):9-13. PubMed ID: 31524656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG4 Expression in Patients with Eosinophilic Otitis Media.
    Takahashi M; Oka A; Kariya S; Gion Y; Sato Y; Iwasaki S; Oyamada S; Matsubara A; Okano M
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(3):167-171. PubMed ID: 33691317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of periostin in eosinophilic otitis media.
    Nishizawa H; Matsubara A; Nakagawa T; Ohta N; Izuhara K; Shirasaki T; Abe T; Takeda I; Shinkawa H
    Acta Otolaryngol; 2012 Aug; 132(8):838-44. PubMed ID: 22667462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y; Usubuchi H; Kodama K; Kanazawa H; Takizawa K; Kanazawa T; Ohta Y
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periostin in middle ear mucosa according to eosinophilic otitis media severity: Middle ear pathology-based treatment.
    Esu Y; Masuda M; Yoshida N
    Auris Nasus Larynx; 2020 Aug; 47(4):527-535. PubMed ID: 32586742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical diagnosis and treatment of eosinophilic otitis media].
    Zhang YZ; Wei XY; Chen ZC; Sun M; Cheng Y; Gao Y; Chen FY; Hu J; Xu M; Zhang Q; Fan MY
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):160-163. PubMed ID: 30808144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.